Concern grows over reaction to deaths in clinical trials.
Macilwain
C
C
D000998:Antiviral Agents / Q000009:adverse effects*; D001086:Arabinofuranosyluracil / Q000009:adverse effects / Q000031:analogs & derivatives*; D002986:Clinical Trials as Topic / Q000592:standards*; D006801:Humans; D009316:National Institutes of Health (U.S.); D014481:United States; D014486:United States Food and Drug Administration
D000998:Antiviral Agents; D001086:Arabinofuranosyluracil; C043457:fialuridine